Habil F Khorakiwala, founder, chairman and group CEO of Wockhardt says the company has replied to US food and drug administration (FDA) on issues related to its L1, Waluj and Shendra facilities and although a few issues are pending, he hopes it will be resolved soon
first published: Feb 16, 2016 12:39 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty extends fall to the 3rd day, breaks below 26,100 | Closing Bell
Live: Can Nifty hold 26,200, break 2-day dull performance? | Opening Bell
Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell
Live: Will Nifty's weakness continue for the second straight day? | Opening Bell
